Seelos Therapeutics

About:

Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics.

Website: https://seelostherapeutics.com/

Twitter/X: seelostx

Top Investors: Michael J. Fox Foundation, The Lind Partners

Description:

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders. The Company's robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases.

Total Funding Amount:

$66.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

1987-01-01

Contact Email:

info(AT)seelostx.com

Founders:

Raj Mehra

Number of Employees:

11-50

Last Funding Date:

2024-05-16

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai